Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of cancer. Its Orascovery product candidates include Oraxol, an oral dosage form, which is in a Phase III trial in metastatic breast cancer for the treatment of advanced gastric cancer; Oratecan, an anticancer agent that is in a Phase 1 study for the treatment of colorectal, lung, ovarian, cervical, pancreatic, upper gastrointestinal, and brain cancer; Oradoxel, an anticancer agent, which is in a Phase 1 clinical study in the treatment of breast, prostate, gastric, head and neck, and lung cancer; and Oratopo, an anticancer for the treatment of cervical, ovarian ,and lung cancer. The company also develops KX-01, a compound, which is in Phase 3 study for the treatment of for actinic keratosis; and KX-02 for the treatment of gliomas. The company was formerly known as Kinex Pharmaceuticals LLC and changed its name to Athenex, Inc. in August 2015. Athenex, Inc. was founded in 2003 and is based in Buffalo, New York. O/S = 56.94M Float = 13.61M Good recent IPO play. Played it and then got back in for a swing - as long as the PPS keep going up.
So far so good and hope it keeps on and follows CVNA that homosapen dropped in daily thread earlier this month that i didn't play - did a double from around the same levels as this IPO.
Im still in here, we got some good news today looks like. https://globenewswire.com/news-rele...rug-Application-of-Oraxol-to-Chinese-FDA.html At this point a 50% loss in pps would see me just about break even, so Ill be holding onto this one for a bit. I also got in another IPO through Motif called DOVA, which has seen steady gains as well. Its also a biotech/ pharma company.
Very extended and think this is going to pull back plus want/need some extra play money so am out now.
